← Leaderboards
James M Manning
Yeshiva University
$1,809,322
Attributed
$1,809,322
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $234.2K · FY2005–11$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,809,322 · 17
By mechanism
P01$1,008,579 · 1
R01$751,626 · 1
P41$49,117 · 15
Top collaborators
No co-investigators on record.
Most similar at Yeshiva University
Same institution · by research overlap
- Joel M Friedman$9,068,244
- Mary E Fabry$5,134,014
- Ronald L Nagel$7,416,455
- Frank A Ferrone$3,953,262
- Robin Walt Briehl$1,617,448
Others in their field
Top investigators on “Hemoglobin”
- John M Lachin · George Washington University$134,552,372
- David M Nathan · Massachusetts Institute Of Technology$123,579,624
- Rose A Gubitosi-Klug · Case Western Reserve University$60,881,424
- Rohit Varma · University Of Southern California$56,341,998
- Anastassios G Pittas · Tufts Medical Center$38,762,359
- Lihong Wang · Texas A&M University System$33,028,686
Research focus
HemoglobinDimerUnited States National Institutes Of HealthSourceGrantFundingResourcesEmbryoHemoglobin SsComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelInstitutionRecombinant ProteinsProteinsAdultBiomedical ResourceMonomerMacromoleculeMutantAmino AcidsIonsCrosslinkBiomedical FacilityAffect
Grant awards (27)
E DIFFS AT SUBUNIT INTERFACES OF HUMAN HBS CORRELATE WITH THEIR DEV PROFILE$2,607
P41 · FY2011 · RR · contact PI
INFLUENCE OF AA SUBSTITUTIONS ON STABILITY OF TETRAMER-DIMER INTERFACE OF HBS$1,304
P41 · FY2011 · RR · contact PI
E DIFFS AT SUBUNIT INTERFACES OF HUMAN HBS CORRELATE WITH THEIR DEV PROFILE$2,321
P41 · FY2010 · RR · contact PI
INFLUENCE OF AA SUBSTITUTIONS ON STABILITY OF TETRAMER-DIMER INTERFACE OF HBS$2,321
P41 · FY2010 · RR · contact PI
HUMAN EMBRYONIC, FETAL, & ADULT HBS HAVE DIFFERENT SUBUNIT INTERFACE STRENGTHS$2,367
P41 · FY2009 · RR · contact PI
INFLUENCE OF AA SUBSTITUTIONS ON STABILITY OF TETRAMER-DIMER INTERFACE OF HBS$2,367
P41 · FY2009 · RR · contact PI
HUMAN EMBRYONIC, FETAL, & ADULT HBS HAVE DIFFERENT SUBUNIT INTERFACE STRENGTHS$2,218
P41 · FY2008 · RR · contact PI
ON STABILITY OF TETRAMER-DIMER INTERFACE OF HUMAN HEMOGLOBINS$3,767
P41 · FY2007 · RR · contact PI
N-TERMINAL ACETYLATION AND PROTONATION OF INDIVIDUAL HEMOGLOBIN SUBUNITS$3,767
P41 · FY2007 · RR · contact PI
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$229,305
P01 · FY2006 · HL · contact PI
ON STABILITY OF TETRAMER-DIMER INTERFACE OF HUMAN HEMOGLOBINS$2,466
P41 · FY2006 · RR · contact PI
N-TERMINAL ACETYLATION AND PROTONATION OF INDIVIDUAL HEMOGLOBIN SUBUNITS$2,466
P41 · FY2006 · RR · contact PI
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$222,919
P01 · FY2005 · HL
THE N-TERMINAL SEQUENCE AFFECTS DISTANT HELIX INTERACTIONS IN HEMOGLOBIN$2,380
P41 · FY2005 · RR
SUBSTRATE INHIBITION OF D-AMINO ACID TRANSAMINASE$1,190
P41 · FY2005 · RR
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$216,717
P01 · FY2004 · HL
N-TERMINAL SEQUENCE AFFECTS DISTANT HELIX INTERACTIONS$1,178
P41 · FY2004 · RR
CHEMICAL &RECOMBINANT STUDIES ON SICKLE CELL HEMOGLOBIN$258,077
R01 · FY2002 · HL
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$150,355
P01 · FY2002 · HL
CHEMICAL &RECOMBINANT STUDIES ON SICKLE CELL HEMOGLOBIN$252,170
R01 · FY2001 · HL
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$0
P01 · FY2001 · HL
POLYMERIZATION OF RECOMBINANT SICKLE HEMOGLOBIN MUTANTS: TRANSGENIC MOUSE MODEL$0
P41 · FY2001 · RR
TRANSAMINASE COFACTOR$0
P41 · FY2001 · RR
CHEMICAL &RECOMBINANT STUDIES ON SICKLE CELL HEMOGLOBIN$241,379
R01 · FY2000 · HL
CORE--FACILITY FOR RECOMBINANT AND MODIFIED SICKLE HEMOGLOBINS$189,283
P01 · FY2000 · HL
POLYMERIZATION OF RECOMBINANT SICKLE HEMOGLOBIN MUTANTS: TRANSGENIC MOUSE MODEL$8,199
P41 · FY2000 · RR
TRANSAMINASE COFACTOR$8,199
P41 · FY2000 · RR